Benefits of a second comparative examine have been reported by Flinn et al. This is the phase III randomized Intergroup demo evaluating FC routine vs . FAMP by yourself in 278 people getting their initially chemotherapy routine for B-CLL. Dosages of FC routine have been the same as the 1st https://erict006dpz1.jts-blog.com/profile